ENTITY

Sinopep-Allsino Bio Pharmaceutical (688076 CH)

10
Analysis
Health CareChina
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. researches, develops, manufactures, and sells peptide drugs and small molecule drugs. The Company produces liraglutide, somalutide, alogliptin benzoate, bivalirudin, eptifibatide, and more. Sinopep-Allsino Bio Pharmaceutical applies its products in treatment of diabetes, cardiovascular diseases, tumors, and other fields.
more
Presentation Icon
No presentations found
We’ll display presentations we find for Sinopep-Allsino Bio Pharmaceutical here
x